Is US advocacy for diabetes dead?

Oh boy. Elisabeth Rosenthal’s piece in the NY Times, Even Small Medical Advances Can Mean Big Jumps in Bills got a lot of attention for all the wrong reasons, which is what really makes me disappointed. I know the headline is not exactly on point. But when I consider the expense of something [...]



from diabetes 24-7 http://ift.tt/1nl9W1o